1st Quarter - Report

WILLIAMS AND JENSEN, PLLC for NOVARTIS INC

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Funding for pandemic influenza countermeasures. Pandemic All Hazards Preparedness Act.

LobbyistCovered position, as disclosed
MATTHEW B HOEKSTRA —
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Medicare prescription drug benefit; Rebates for Medicare Part D; Independent Payment Advisory Board (IPAB). House and Senate Budget resolutions; Continuing Resolution Appropriations for FY 2013 (H.R. 933)

LobbyistCovered position, as disclosed
JENNY DIJAMES —
SUSAN HIRSCHMANN —
KARINA LYNCH —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 933 (113th)

Health Issues HCR

Drug safety and drug counterfeiting (track and trace); Drug importation; Authorized generics; Drug company patent settlements; Prescription drug advertising; Federal preemption for prescription drugs; implementation of the Patient Protection and Affordable Care Act;and drug shortages.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH —
MELINDA M MAXFIELD —
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.